This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pugliese, M. S. Articles by Beatty, J D. Search for Related Content PubMed PubMed Citation Articles by Pugliese, M. S. Articles by Beatty, J D.

The Utility of Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer

¹ Department of Surgery, Comprehensive Breast Cancer Program, Swedish Cancer Institute, 1221 Madison Street, Suite, 400 Seattle, Washington
² Department of Pathology, Comprehensive Breast Cancer Program, Swedish Cancer Institute, 1221 Madison Street, Suite, 400 Seattle, Washington
³ Department of Research, Comprehensive Breast Cancer Program, Swedish Cancer Institute, 1221 Madison Street, Suite, 400 Seattle, Washington

Correspondence: Address correspondence and reprint requests to: J David Beatty, MD; E-mail: david.beatty{at}swedish.org

Background: In breast cancer treatment, intraoperative sentinel lymph node (SLN) evaluation is used to identify patients who may potentially benefit from immediate completion of axillary lymph node dissection.

Methods: Prospectively collected breast cancer registry data identified 516 SLN biopsies between January 2003 and December 2005. Intraoperative evaluation (IE) of the SLNs was performed in 479 axillae. Final pathology by hematoxylin and eosin and, for negative nodes, by immunohistochemical stains was compared with the IE result. The effect of IE and final pathology on surgical treatment was examined.

Results: The sensitivities for IE of N0(i+) (n = 39), N1mi (n = 41), and N1a–3a (n = 89) metastases were 0%, 5%, and 63%, respectively. The specificity was 99.7%. IE identified 57 (44%) of SLN-positive (N1mi and N1a–3a) axillae, thus resulting in synchronous axillary lymph node dissection for those patients. Reoperation for false-negative IEs (N1mi or N1a–3a with negative IE) occurred in only 27 axillae (39%).

Conclusions: IE of SLNs has adequate sensitivity and excellent specificity. In addition to allowing patients to benefit from synchronous surgery, IE helped patients to receive care in concordance with recommended practice guidelines. The false-negative IE of SLNs highlights uncertainty with the clinical significance of axillary nodal staging when only small amounts of metastatic disease are identified in the axilla.

Key Words: Breast cancer • Axillary lymph node dissection • Sentinel lymph node • Intraoperative evaluation • Imprint cytology • Frozen section